Patent assignee · US · COMPANY

Facet Biotech Corporation

17Patents
15Active
17Granted
45Portfolio score

Filing activity: Nov 5, 2004 → Aug 12, 2009 · 15 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7592004B2 Stable lyophilized pharmaceutical formulation of IgG antibodies Human Necessities 35 Expired
US7709610B2 Therapeutic use of anti-CS1 antibodies Chemistry; Metallurgy 27 Active
US7662384B2 Use of anti-α5β1 antibodies to inhibit cancer cell proliferation Chemistry; Metallurgy 16 Expired
US7666419B2 Anti-CCR5 antibody Chemistry; Metallurgy 12 Active
US7732195B2 Tethered vectors for cell surface immunoglobulin display Chemistry; Metallurgy 9 Active
US7732570B2 Alteration of Fc-fusion protein serum half-lives by mutagenesis Chemistry; Metallurgy 7 Active
US7807163B2 Antibodies against GPR64 and uses thereof Chemistry; Metallurgy 6 Active
US7842293B2 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma Human Necessities 4 Active
US7674883B2 Antibodies against cancer antigen TMEFF2 and uses thereof Chemistry; Metallurgy 3 Active
US7824678B2 Antibodies against cancer antigen TMEFF2 and uses thereof Chemistry; Metallurgy 2 Active
US7785816B2 Antibodies against cancer antigen TMEFF2 and uses thereof Chemistry; Metallurgy 1 Active
US7851600B2 Anti-CCR5 antibody Chemistry; Metallurgy 1 Active
US8298530B2 Stable lyophilized pharmaceutical formulation of IgG antibodies Human Necessities 0 Active
US7547544B2 Antibodies against GPR64 and uses thereof Chemistry; Metallurgy 0 Active
US7914789B2 HEMCM42 antibodies Human Necessities 0 Active
US7879987B2 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis Chemistry; Metallurgy 0 Active
US7776585B2 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.